We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
7034 Background: Taxanes and vinca alkaloids are commonly used agents, in first-line therapy of advanced NSCLC. As some data in comparative studies have suggested possible differences in survival and(More)
  • 1